Update on Adjuvant Trials for Pancreatic Cancer
Adjuvant therapy for pancreatic cancer remains a controversial topic, with a paucity of randomized controlled trials in this area and various limitations in the trials that have been conducted to…
ONCOLOGY
Management of Borderline Resectable Pancreatic Cancer
Borderline resectable pancreatic cancer is an emerging stage of disease defined by computed tomogrpahy criteria, patient (Katz type B), or disease characteristics (Katz type C). These patients are particularly well…
Quality Improvement for Pancreatic Cancer Care: Is Regionalization a Feasible and Effective Mechanism?
Variability exists in the quality of pancreatic cancer care provided in the United States. High-volume centers have been shown to have improved outcomes for pancreatectomy. Regionalization of pancreatic cancer care…
Laparoscopic Surgery for Pancreatic Tumors
The rapid growth of minimally invasive technology and experience in recent decades has revolutionized many aspects of oncologic surgery. Adoption of laparoscopic pancreatectomy has been slow due to the inherent…
Current Concepts in the Surgical Management of Pancreatic Cancer
Pancreatic ductal adenocarcinoma (PDA) is the most common pancreatic malignancy comprising approximately 85% of cases. Many aspects of surgical resection of pancreatic cancer have been evaluated as to their effects…
Cystic Neoplasms of the Pancreas
Cystic neoplasms of the pancreas are a heterogeneous group of pancreatic tumors that vary in pathophysiology, malignant potential, clinical course, and outcomes. Their management is heavily predicated on establishing an…
The Management of Intraductal Papillary Mucinous Neoplasms of the Pancreas
Intraductal papillary mucinous neoplasms (IPMN) are mucinous cystic tumors of the pancreas, which were first classified into a unified diagnosis by the World Health Organization in 1996. These lesions originate…
Endoscopic Ultrasound Staging and Novel Therapeutics for Pancreatic Cancer
Pancreatic cancer remains a challenging disease, being the fourth leading cause of death in both men and women in the United States. Patients with pancreatic cancer present with symptoms including…
PET and PET/CT for Pancreatic Malignancies
FDG PET imaging is useful for preoperative diagnosis of pancreatic carcinoma in patients with suspected pancreatic cancer in whom CT fails to identify a discrete tumor mass or in whom…
Adjuvant Chemotherapy in Early-Stage Breast Cancer: What, When, and for Whom?
Adjuvant chemotherapy is effective in reducing the risk of recurrence and death from breast cancer. Tumor stage and biologic characteristics are important when making decisions about who should receive chemotherapy…
